MYR Pharma Completes Phase 2b Study of Myrcludex B


XableCath's Peripheral Arterial Catheters Gets US Patent


Avillion Inks Drug Development Deal with Pearl Therapeutics


Biocon & Mylan's Biosimilar Trastuzumab Gets ANVISA Nod


Takeda to Acquire TiGenix for EUR 520 Million


Mallinckrodt Seeks US FDA Approval for Stannsoporfin


US FDA Approves to Market Lupin's Generic Dovonex Scalp Solution


US FDA Accepts NDA for Acacia Pharma's Baremsis


Datavant, Verge Genomics Ink Strategic Drug Development Deal


US FDA Okays Marketing of Zydus' Clomipramine HCl Capsules


US FDA Accepts GW Pharma's NDA Filing for Epidiolex


BioMatrix Partners with Genentech


Kernal Biologics & QurAlis Win Amgen Golden Ticket at LabCentral


Rimidi, Eli Lilly Ink Deal


Medicure Acquires Exclusive License to Sell & Market Branded Cardiovascular Drug in US


DKSH India Wins Ashland "Best Channel Partner" Award for Rest of Asia Region


Pfizer's Psoriatic arthritis Drugs Get US FDA Nod


Gilead Sciences to Appoint John C Martin as New Chairman


Cipla Gets US FDA Nod for Generic Pulmicort Respules


Chugai to Sell Production Right of 13 Medication to Taiyo Pharma


AstraZeneca Receives US FDA Approval for Faslodex


DCGI Approves Heteros Generic FDC Drug 'Darunavir + Ritonavir'


Novartis Join Hands with ASCP & ACS to Fight Cancer in Sub-Saharan Africa


Sawai Forms Strategic Alliance with Sumitomo Corporation


EC Approves Sandoz's Rixathon


Merrimack Completes Enrollment in Phase 2 CARRIE Study of MM-141


Axovant Sciences Receives US FDA Fast Track Status for Nelotanserin


US FDA Marketing Nod for Zydus Eletriptan Hydrobromide Tablets


RASRx Gets US FDA Orphan Drug Status for RASRx1902


US FDA approves Darzalex in Combo with Pomalidomide & Dexamethasone


PharmaMar to Commercialize PM1183 with Trade Name of Zepsyre


ThromboGenics Appoints Thomas Clay as Chairman


US FDA Approves Lannett Generic Xyzal Oral Solution


Dr Reddy's Generic Doxil Gets US FDA Nod


Boston Scientific Announces Positive Results from REPRISE III Trial


Saudi FDA Approves Sobiís Orfadin Capsules


Novartis Initiative to Tackle Hypertension and its Root Causes


Bayer's Copanlisib Receives Priority Review Status from US FDA


US FDA Approves Monitored Therapeutics' GoSpiro Home Spirometer


Hitgen & Pfizer to Build and Screen Novel DNA Encoded Libraries


US FDA Gives Breakthrough Therapy Designation to Novartis' CTL019


Abeome Inks Research Deal with CDC


CASI Pharma Pauses Patients Enrolment in ENMD-2076 Phase 2 Study


Novotech Signs MoU with SouthKorea's AMC


Protalix Announce Positive Results Alidornase Alfa Phase II Trial


India's Biosimilar Norms Equal with Global Requirements


Glenmark's Generic Pradaxa Capsules Gets US FDA Tentative Approval


Omnicell Buys Mississippi-based nPharmics


Verona Signs Collaboration to Develop Dry Powder and Metered Dose Inhaler Formulations for COPD


Rigel Pharma Submits NDA to US FDA for Fostamatinib


Calypso, EA Pharma to Develop & Market CALY-001


Allergan, Novartis to Conduct Clinical Trial to Treat NASH


Japan Vaccine Co Seeks Japanese Approval for Shingrix


Flow Chemistry for API Commercial Manufacturing


Pfizer's Xeljanz Gets Chinese FDA Nod


Diplomat Pharmacy to Dispense Kisqali for Metastatic Breast Cancer


Biogen Appoints Anirvan Ghosh as sr VP, RED


AstraZeneca Partners with Circassia Pharma


VolitionRx Forms Wholly-owned US Subsidiary


Glenmark Receives US FDA Tentative Approval for Fingolimod Capsules


Zydus Cadila Acquires Sentynl Therapeutics


Lilly to Buy US-based CoLucid Pharma


Caris Life, Lustgarten Foundation Collaborate


Takeda, Ovid Therapeutics Form Global Collaboration for TAK-935


Voxtur Bio Introduces Cardiac Testing Range


leon-nanodrugs, Bionpharma to Develop Dermatological Product